MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$1.52 USD
-0.06 (-3.80%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.52 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MAIA 1.52 -0.06(-3.80%)
Will MAIA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MAIA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MAIA
Best Momentum Stocks to Buy for May 6th
New Strong Buy Stocks for May 6th
MAIA: What are Zacks experts saying now?
Zacks Private Portfolio Services
MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know
Other News for MAIA
MAIA Secures FDA Fast Track for Lung Cancer Treatment
MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for ...
MAIA Biotechnology granted fast track designation for ateganosine
MAIA Biotechnology Publishes Groundbreaking Preclinical Data | MAIA Stock News
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second ...